The Dean’s List of Penny Stock Price Gainers for July 28: (EFGU, NDYN, ISCO, URRE, GNBT)
July 28th, 2010 at 4:53 pm Posted by The Dean
The Dean hopes everyone had a profitable day of trading today. Make sure to do your homework on this list of penny stock price gainers for Wednesday, July 28, 2010:
EFGU $0.04 +122.22%
Although Empire Film Group, Inc. (PINK: EFGU) hasn’t issued news in almost a month, the company’s stock traded nearly 9 times its 90-day average volume. Today, EFGU shares gained as much as 127% over yesterday’s close of $0.018, hitting a high of $0.041.
NDYN $0.075 +56.25%
Naerodynamics, Inc. (PINK: NDYN) was another mover on no news, trading 1,111,271 shares, or more than 17 times is 3 month average volume. NDYN soared as much as 75%, hitting a high of $0.084 in trading today.
ISCO $1.37 +22.32%
This morning, International Stem Cell Corporation (OTC: ISCO) announced its wholly-owned subsidiary, Lifeline Cell Technology, entered into an agreement with Sristi Biosciences for the distribution of its Lifeline brand of human cell culture products in India. Today’s news comes after a last week’s announcement that the Company entered into a memorandum of understanding with ARG Vermogensverwaltung AG (“ARG”), a German investment fund, to create a new European subsidiary to be funded with up to $10 million of capital derived from ARG and other sources in Europe.
URRE $0.53 +12.77%
On Monday, Uranium Resources, Inc. (NASDAQ: URRE) announced it will be holding a teleconference and webcast at 11 am EST on August 9, 2010 to discuss second quarter 2010 financial results. Yesterday afternoon, URRE was mentioned in an IndieResearch report, Uranium Exec Voices Bullish Outlook, where the Company was referred to “laggard” over the last week.
GNBT $0.376 +11.90%
Today, Generex Biotechnology Corporation (NASDAQ: GNBT) announced that the company has achieved 75% of the required number of “per-protocol completers” in its ongoing six-month Phase III study of Generex Oral-lyn, a proprietary buccal insulin spray product. This NASDAQ stock gained more than 17%, trading more than 6 times GNBT’s 10-day average volume today.
